A detailed history of Paradigm, Strategies In Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Paradigm, Strategies In Wealth Management, LLC holds 255 shares of LLY stock, worth $200,988. This represents 0.15% of its overall portfolio holdings.

Number of Shares
255
Previous 281 9.25%
Holding current value
$200,988
Previous $254,000 11.42%
% of portfolio
0.15%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $20,075 - $24,960
-26 Reduced 9.25%
255 $225,000
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $166,408 - $222,630
281 New
281 $218,000
Q3 2021

Oct 15, 2021

SELL
$221.6 - $272.71 $68,696 - $84,540
-310 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$164.32 - $212.72 $50,939 - $65,943
310 New
310 $58,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Paradigm, Strategies In Wealth Management, LLC Portfolio

Follow Paradigm, Strategies In Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm, Strategies In Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm, Strategies In Wealth Management, LLC with notifications on news.